Zixuan Zhao1, Shuyan Gu2, Yi Yang3

  • 1Department of Public Administration, School of Health Economics and Management, Nanjing University of Chinese Medicine, Nanjing, China.

BMC cancer
|January 13, 2024
PubMed
概括

多基因风险评分 (PRS) 肺癌查在中国不具有成本效益. 低剂量计算机断层扫描 (LDCT) 查仍然是检测肺癌和降低死亡率的最佳策略.